HIGHLIGHTS
- What: This study reported that the allogenic transplantation of endothelial cells was safe and effectively enhanced the patency of AVFs/AVGs. This study showed that targeted local therapy with perivascular and allogenic endothelial cells is a safe and novel therapeutic approach based on phase I (followed for 30 days) and phase II (24-week follow-up) study data . The patients from this trial had improved white blood cell counts, improved neutrophil counts, and improved platelets.
- Who: Gaurav Baranwal and collaborators from the (UNIVERSITY) have published the Article: Advancements in Mesenchymal Stem Cell-Based Therapy for . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.